Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection
2024

Understanding Antibody Responses After COVID-19 Infection

Sample size: 27 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kuijper Lisan H., Kreher Christine, Elias George, Claireaux Mathieu, Kerster Gius, Bos Amélie V., Duurland Mariël C., Konijn Veronique A. L., Paul Alberta G. A., de Jong Nina, de Jongh Rivka, Steenhuis Maurice, Garcia-Vallejo Juan J., van Gils Marit J., Kuijpers Taco W., Eftimov Filip, Rispens Theo, van der Schoot C. Ellen, van Ham S. Marieke, ten Brinke Anja

Primary Institution: Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Hypothesis

How are long-lived antibody responses regulated after SARS-CoV-2 infection?

Conclusion

Individuals with sustained antibody responses show unique dynamics in B cell responses that enhance antibody quality over time.

Supporting Evidence

  • Individuals with stable antibody levels showed increased neutralization capacity over time.
  • Sustainers had fewer Spike-specific IgG+ memory B cells early after infection.
  • Declining antibody titers correlated with lower frequency of Spike-specific CD4+ T cells.
  • Deep immune profiling revealed distinct B cell dynamics between sustainers and decliners.
  • Both groups had similar frequencies of total SARS-CoV-2-specific B and CD4+ T cells.

Takeaway

Some people keep their antibodies strong for a long time after getting sick with COVID-19, while others lose them quickly. This study looks at why that happens.

Methodology

The study compared B and T cell responses in convalescent individuals with stable versus declining antibody levels after mild COVID-19 infection using deep immune profiling.

Potential Biases

Potential biases may arise from the selection of participants based on antibody levels and the exclusion of those with reinfection signs.

Limitations

The study focused on a limited time frame and did not include longitudinal sampling beyond the initial follow-up.

Participant Demographics

Participants were convalescent individuals over 18 years of age who had mild COVID-19.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1505719

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication